| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000268355.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.046099405 |
Resistant |
| ENSG00000268355.1 |
Afatinib |
Breast invasive carcinoma |
0.036873034 |
Sensitive |
| ENSG00000268355.1 |
Afatinib |
Lung squamous cell carcinoma |
0.042084265 |
Sensitive |
